Presentations
Upcoming presentations
2026-05-18 - Nanexa will participate in DDF Summit 2026 in Berlin, Germany on 18-20 May
Past presentations
2026-04-29 - Q1 report commentary with CEO David Westberg
2026-03-23 - David Westberg, CEO, will participate in BIO-Europe in Lisbon, Portugal on 23-25 March
2026-02-19 - Q4 report commentary with CEO David Westberg and Chairman of the Board Göran Ando
2025-12-11 - Nanexa and Moderna enter into license and option agreements
2025-11-06 - Q3 report commentary with CEO David Westberg
2025-11-03 - Bridget Lacey, Chief Business Officer, will attend BIO-Europe in Vienna on November 3-5
2025-10-28 - CPHI, Frankfurt. Meet Mårten Rooth, CTO.
2025-10-27 - PODD, Boston. Meet David Westberg CEO & Bridget Lacey, CBO
2025-08-27 - Q2 report commentary with CEO David Westberg
2025-07-14 - Controlled Release Society (CRS) Annual Meeting in Philadelphia, USA
2025-06-22 - Poster presented at American Diabetes Association (ADA), 22 June
2025-06-16 - Interview with CEO David Westberg from The Pharma Navigator
2025-06-03 - DDF Summit, Drug Delivery & Formulation i Berlin
2025-05-06 - Q1 report commentary with CEO David Westberg
2025-02-19 - Q4 report commentary with CEO David Westberg and Chairman of the board Göran Ando
2025-02-13 - Extraordinary General Meeting
2024-11-25 - Phase I study for NEX-22 result presentation and Q&A